Breast Care Quality Metrics

Commission on Cancer's Quality of Care Measures

UC San Diego Health's cancer program is accredited by the Commission on Cancer (CoC), which collects standardized data from CoC-accredited health care settings to measure cancer care quality.

The data presented below is included in the CoC's quality of care measures for breast cancer, and are for diagnosis year 2013, the most recent year for which data is available. (Data provided by the National Cancer Database.)  

The purpose of the data is to compare the care of breast cancer patients at UC San Diego Health with other CoC-accredited cancer programs regionally and nationwide. UC San Diego's results compare favorably in all below meaures. For more information about quality and safety measures, see Quality Care.

Administration of hormone therapy is considered within one year of diagnosis (when appropriate)

UC San Diego Health 96.2%
State of California 88.2%
Pacific Region 90.6%
Teaching Hospitals 91.9%
All Commission on Cancer Approved Programs 92.0%

Image-guided or palpation-guided needle biopsy to the primary site is performed to establish diagnosis

UC San Diego Health 100%
State of California 91.5%
Pacific Region 91.2%
Teaching Hospitals 91.4%
All Commission on Cancer Approved Programs 90.8%

Radiation therapy is recommended or administered following any mastectomy within one year of diagnosis (when appropriate)

UC San Diego Health 95.0%
State of California 83.8%
Pacific Region 86.7%
Teaching Hospitals 89.1%
All Commission on Cancer Approved Programs 89.3%

Radiation is administered within one year of diagnosis for women receiving breast conservation surgery (when appropriate).

UC San Diego Health 94.9%
State of California 89.4%
Pacific Region 91.0%
Teaching Hospitals 91.8%
All Commission on Cancer Approved Programs 92.1%